(Q39459724)

12 September 2017

Reflex sympathetic dystrophy treated with gabapentin (English)

1 reference

12 September 2017

0 references

1 reference

G A Mellick

1

1 reference

PubMed ID

9014968

12 September 2017

L B Mellick

series ordinal

2

1 reference

12 September 2017

1 January 1997

1 reference

Archives of Physical Medicine and Rehabilitation

12 September 2017

1 reference

12 September 2017

78

1 reference

12 September 2017

1

1 reference

12 September 2017

98-105

1 reference

Reflex sympathetic dystrophy. A review

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Reflex sympathetic dystrophy as a probable paraneoplastic syndrome: case report and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Long-term treatment with gabapentin for partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Comparison of gabapentin with other antiepileptic and GABAergic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Time-course variations in tyrosine hydroxylase activity in the rat locus coeruleus after electrolytic destruction of the nuclei raphe dorsalis or raphe centralis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Alteration of tyrosine hydroxylase activity in the locus coeruleus after administration of p-chlorophenylalanine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Regulation of central alpha-adrenoceptors by serotoninergic denervation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

A new major projection from locus coeruleus: the main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Three bulbospinal pathways from the rostral medulla of the cat: An autoradiographic study of pain modulating systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Peripheral and spinal mechanisms of nociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Axonal trajectories and terminations of on- and off-cells in the cat lower brainstem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Bulbospinal projections in the primate: a light and electron microscopic study of a pain modulating system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: Further studies on the anatomy of pain modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Ultrastructural analysis of medial brain stem afferents to the superficial dorsal horn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Reexamination of the dorsal root projection to the spinal dorsal horn including observations on the differential termination of coarse and fine fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Brainstem Control of Spinal Pain-Transmission Neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Spinal and Trigeminal Mechanisms of Nociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Origins of serotonergic projections to the spinal cord in rat: an immunocytochemical-retrograde transport study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Distribution of mu-opioid receptors in the nucleus raphe magnus and nucleus gigantocellularis: a quantitative autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Substance P-immunoreactive and serotonin-containing neurones in the ventral brainstem of the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

The topographical distribution of serotoninergic terminals in the spinal cord of the cat: biochemical mapping by the combined use of microdissection and microassay procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Effects of 5-hydroxytryptamine applied into nucleus raphe magnus on nociceptive thresholds and neuronal firing rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

The effect of modification of 5-hydroxytryptamine function in nucleus raphe magnus on nociceptive threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Analgesic effects of serotonin microinjection into nucleus raphe magnus and nucleus raphe dorsalis evaluated by the monosodium urate (MSU) tonic pain model in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Stimulation-produced spinal inhibition from the midbrain in the rat is mediated by an excitatory amino acid neurotransmitter in the medial medulla.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Morphological study of noradrenaline innervation in the caudal raphe nuclei with special reference to fine structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Neurotransmitters in Nociceptive Modulatory Circuits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Peptides and the primary afferent nociceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Gabapentin augments whole blood serotonin in healthy young men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Biogenic amines and the states of sleep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Pain mechanisms: a new theory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behavior in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

Management of restless legs syndrome with gabapentin (Neurontin)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2897%2990020-4

10.1016/S0003-9993(97)90020-4

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

9014968